News | Mammography | August 11, 2015

Legislation would delay implementation of controversial breast cancer screening coverage recommendations for two years

ACR, SBI, Congress, PALS Act, Protecting Access to Lifesaving Screenings

August 11, 2015 — The American College of Radiology (ACR) and the Society of Breast Imaging (SBI) are encouraging congressional leaders to pass the Protecting Access to Lifesavings Screenings Act (H.R. 3339). Passage of the act would ensure women who want to get regular mammograms retain insurance coverage with no copay and avert thousands of unnecessary deaths.

The ACR and SBI strongly support the PALS Act as a way to delay implementation of draft breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF) for two years. They singled out Reps. Renee Ellmers (R-NC) and Debbie Wasserman Schultz (D-FL) for introducing H.R. 3339 and encouraged the House and Senate to act quickly to pass the legislation.

"The two-year delay allows consideration of recent large studies that showed mammography to be far more effective than the old studies the USPSTF analyzed. It also provides time for Congress to enact separate legislation that mandates a badly needed overhaul of the closed and outdated USPSTF process," said Debra Monticciolo, M.D., FACR, chair of the American College of Radiology Breast Imaging Commission.

The Affordable Care Act (ACA) requires private insurers to cover exams without patient cost sharing given a grade of "B" or higher by the USPSTF. The Task Force gave routine screening of women ages 40-49 a "C" grade and gave a "B" grade only to biennial (every other year) screening for women 50-74. This would indicate that women ages 40-49 that choose routine screening and those 50-74 who want annual screening would not be guaranteed coverage. This may drastically impact underserved and rural areas.

According to National Cancer Institute data, since mammography screening became widespread in the mid-1980s, the U.S. breast cancer death rate has dropped 35 percent. Published analysis, using the task force’s 2009 methodology, showed that if women ages 40-49 go unscreened and those 50-74 are screened biennially, approximately 6,500 additional women each year in the United States would die from breast cancer. Many more would experience more extensive and expensive treatments than if their cancers were found early by a regular mammogram.

"The closed USPSTF process does not meet Institute of Medicine (IOM) standards for 'trustworthy' guidelines creation and needs updating. These USPSTF mammography recommendations are suspect until ACR and SBI recognized experts are included in a meaningful way in their creation," said Elizabeth A. Morris, M.D., FACR, president of the Society of Breast Imaging.

For more information: www.acr.org, www.sbi-online.org


Related Content

News | Artificial Intelligence

April 19, 2024 — Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology ...

Time April 22, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
News | Mammography

April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...

Time April 11, 2024
arrow
News | Society of Breast Imaging (SBI)

April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...

Time April 11, 2024
arrow
Subscribe Now